Literature DB >> 18821249

3D Pharmacophore, hierarchical methods, and 5-HT4 receptor binding data.

Thibault Varin1, Nicolas Saettel, Jonathan Villain, Aurelien Lesnard, François Dauphin, Ronan Bureau, Sylvain Rault.   

Abstract

5-Hydroxytryptamine subtype-4 (5-HT(4)) receptors have stimulated considerable interest amongst scientists and clinicians owing to their importance in neurophysiology and potential as therapeutic targets. A comparative analysis of hierarchical methods applied to data from one thousand 5-HT(4) receptor-ligand binding interactions was carried out. The chemical structures were described as chemical and pharmacophore fingerprints. The definitions of indices, related to the quality of the hierarchies in being able to distinguish between active and inactive compounds, revealed two interesting hierarchies with the Unity (1 active cluster) and pharmacophore fingerprints (4 active clusters). The results of this study also showed the importance of correct choice of metrics as well as the effectiveness of a new alternative of the Ward clustering algorithm named Energy (Minimum E-Distance method). In parallel, the relationship between these classifications and a previously defined 3D 5-HT(4) antagonist pharmacophore was established.

Mesh:

Substances:

Year:  2008        PMID: 18821249     DOI: 10.1080/14756360802204748

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  3 in total

1.  Brain serotonergic circuitries.

Authors:  Yves Charnay; Lucienne Léger
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

2.  Weighted voting-based consensus clustering for chemical structure databases.

Authors:  Faisal Saeed; Ali Ahmed; Mohd Shahir Shamsir; Naomie Salim
Journal:  J Comput Aided Mol Des       Date:  2014-05-15       Impact factor: 3.686

3.  Voting-based consensus clustering for combining multiple clusterings of chemical structures.

Authors:  Faisal Saeed; Naomie Salim; Ammar Abdo
Journal:  J Cheminform       Date:  2012-12-17       Impact factor: 5.514

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.